Effects of the Natural Flavone Trimethylapigenin on Cardiac Potassium Currents
Yi Liu,Xiao-Hui Xu,Zheng Liu,Xin-Ling Du,Kui-Hao Chen,Xin,Zhen-Dong Jin,Ji-Zhong Shen,Yan Hu,Gui-Rong Li,Man-Wen Jin
DOI: https://doi.org/10.1016/j.bcp.2012.05.002
IF: 6.1
2012-01-01
Biochemical Pharmacology
Abstract:The natural flavones and polymethylflavone have been reported to have cardiovascular protective effects. In the present study, we determined whether quecertin, apigenin and their methylated compounds (3,7,3′,4′-tetramethylquecertin, 3,5,7,3′,4′-pentamethylquecertin, 7,4′-dimethylapigenin, and 5,7,4′-trimethylapigenin) would block the atrial specific potassium channel hKv1.5 using a whole-cell patch voltage-clamp technique. We found that only trimethylapigenin showed a strong inhibitory effect on hKv1.5 channel current. This compound suppressed hKv1.5 current in HEK 293 cell line (IC50=6.4μM), and the ultra-rapid delayed rectify K+ current IKur in human atrial myocytes (IC50=8.0μM) by binding to the open channels and showed a use- and frequency-dependent manner. In addition, trimethylapigenin decreased transient outward potassium current (Ito) in human atrial myocytes, inhibited acetylcholine-activated K+ current (IC50=6.8μM) in rat atrial myocytes. Interestingly, trimethylapigenin had a weak inhibition of hERG channel current. Our results indicate that trimethyapigenin significantly inhibits the atrial potassium currents hKv1.5/IKur and IKACh, which suggests that trimethylapigenin may be a potential candidate for anti-atrial fibrillation.